Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-393462

Shareholder rights changed · Bylaws or fiscal year change

  • Item 3.03 Material modification to rights of security holders
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading tcrt-20260916.htm…